| Pharmacy education and practice in 13 Middle Eastern countries N Kheir, M Zaidan, H Younes, M El Hajj, K Wilbur, PJ Jewesson American journal of pharmaceutical education 72 (6), 2008 | 294 | 2008 |
| A critical reevaluation of the “therapeutic range” of aminoglycosides JP McCormack, PJ Jewesson Clinical infectious diseases 14 (1), 320-339, 1992 | 182 | 1992 |
| Pharmacokinetics and safety of antimicrobial agents during pregnancy AW Chow, PJ Jewesson Reviews of infectious diseases 7 (3), 287-313, 1985 | 176 | 1985 |
| Industry sponsorship and authorship of clinical trials over 20 years SS Buchkowsky, PJ Jewesson Annals of Pharmacotherapy 38 (4), 579-585, 2004 | 141 | 2004 |
| An assessment of quality of sleep and the use of drugs with sedating properties in hospitalized adult patients L Frighetto, C Marra, S Bandali, K Wilbur, T Naumann, P Jewesson Health and Quality of Life Outcomes 2, 1-10, 2004 | 131 | 2004 |
| Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans F Marra, GM Robbins, BA Masri, C Duncan, KM Wasan, EH Kwong, ... Canadian Journal of Surgery 44 (5), 383, 2001 | 128 | 2001 |
| Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme: a Canadian teaching hospital and ministry of health perspective AO Wai, L Frighetto, CA Marra, E Chan, PJ Jewesson Pharmacoeconomics 18, 451-457, 2000 | 119 | 2000 |
| Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated … A Kureishi, PJ Jewesson, M Rubinger, CD Cole, DE Reece, GL Phillips, ... Antimicrobial agents and chemotherapy 35 (11), 2246-2252, 1991 | 101 | 1991 |
| Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin WR Bowie, V Willetts, PJ Jewesson Antimicrobial agents and chemotherapy 33 (10), 1778-1782, 1989 | 100 | 1989 |
| Nonvalue of antigen detection immunoassays for diagnosis of candidemia P Phillips, A Dowd, P Jewesson, G Radigan, MG Tweeddale, A Clarke, ... Journal of Clinical microbiology 28 (10), 2320-2326, 1990 | 97 | 1990 |
| Intravenous-to-oral stepdown program: four years of experience in a large teaching hospital L Frighetto, D Nickoloff, SM Martinusen, FS Mamdani, PJ Jewesson Annals of Pharmacotherapy 26 (11), 1447-1451, 1992 | 79 | 1992 |
| Quality-of-life assessment in an outpatient parenteral antibiotic program AF Goodfellow, AO Wai, L Frighetto, CA Marra, BM Ferreira, ML Chase, ... Annals of Pharmacotherapy 36 (12), 1851-1855, 2002 | 71 | 2002 |
| Pharmacist computer skills and needs assessment survey RM Balen, PJ Jewesson Journal of Medical Internet Research 6 (1), e27, 2004 | 67 | 2004 |
| Sequential antibiotic therapy: effective cost management and patient care LA Mandell, MG Bergeron, MJ Gribble, PJ Jewesson, DE Low, TJ Marrie, ... Canadian Journal of Infectious Diseases and Medical Microbiology 6, 306-315, 1995 | 67 | 1995 |
| Willingness to pay to assess patient preferences for therapy in a Canadian setting CA Marra, L Frighetto, AF Goodfellow, AO Wai, ML Chase, RE Nicol, ... BMC Health Services Research 5, 1-6, 2005 | 66 | 2005 |
| Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients AW Chow, PJ Jewesson, A Kureishi, GL Phillips European Journal of Haematology 51 (S54), 18-24, 1993 | 58 | 1993 |
| Cost-effectiveness and value of an IV switch P Jewesson Pharmacoeconomics 5 (Suppl 2), 20-26, 1994 | 57 | 1994 |
| Continuous intrathecal pump infusion of baclofen with antibiotic drugs for treatment of pump-associated meningitis: Case report PJ Zed, H grant Stiver, V Devonshire, PJ Jewesson, F Marra Journal of neurosurgery 92 (2), 347-349, 2000 | 55 | 2000 |
| Aminoglycoside administration as a single daily dose: an improvement to current practice or a repeat of previous errors? F Marra, N Partovi, P Jewesson Drugs 52 (3), 344-370, 1996 | 52 | 1996 |
| Selecting antibacterials for outpatient parenteral antimicrobial therapy: pharmacokinetic-pharmacodynamic considerations RS Slavik, PJ Jewesson Clinical pharmacokinetics 42, 793-817, 2003 | 51 | 2003 |
Carlo MarraProfessor of PharmacyVerified email at otago.ac.nz
